DCGI approves AstraZeneca’s Lynparza for adjuvant treatment of patients with high-risk early breast…
New data from Olympia phase-III trial suggest that Olaparib demonstrated a statistically significant and clinically meaningful…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.